Julinda Mehilli
Overview
Explore the profile of Julinda Mehilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
380
Citations
10692
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alfonso F, Byrne R, Scheller B, Van Belle E, Mehilli J
EuroIntervention
. 2025 Jan;
21(2):e102-e104.
PMID: 39829353
No abstract available.
2.
Bay B, Gitto M, Sartori S, Vogel B, Tchetche D, Petronio A, et al.
Catheter Cardiovasc Interv
. 2025 Jan;
105(4):891-899.
PMID: 39776285
Background: Limited data exist on the impact of polyvascular disease (PolyVD) on clinical outcomes in female patients undergoing transcatheter aortic valve replacement (TAVR). We therefore sought to investigate clinical outcomes...
3.
Grundmann D, Neubarth-Mayer J, Muller C, Becker F, Reichart D, Stark K, et al.
Am J Cardiol
. 2024 Nov;
238:47-54.
PMID: 39613280
Cardiac allograft vasculopathy (CAV) is a progressive disease with limited options for secondary prevention. Ways to manage lipid parameters and dyslipidemia patterns in care after transplantation remain unclear. In this...
4.
Vrints C, Andreotti F, Koskinas K, Rossello X, Adamo M, Ainslie J, et al.
G Ital Cardiol (Rome)
. 2024 Nov;
25(12 Suppl 1):e1-e132.
PMID: 39611224
No abstract available.
5.
Di Muro F, Vogel B, Sartori S, Tchetche D, Feng Y, Petronio A, et al.
Am J Cardiol
. 2024 Nov;
236():56-63.
PMID: 39522578
Limited evidence exists concerning the prognostic impact of baseline left ventricular ejection fraction (LVEF) on outcomes among women undergoing transcatheter aortic valve implantation (TAVI), which we aimed to investigate in...
6.
Orban M, Kuehl A, Pechmajou L, Muller C, Sfeir M, Brunner S, et al.
J Card Fail
. 2024 Oct;
30(10):1222-1230.
PMID: 39389730
Background: Percutaneous coronary intervention (PCI) might improve outcome at severe stages of cardiac allograft vasculopathy (CAV) among patients after heart transplantation (HTx). Yet, risk stratification of HTx patients after PCI...
7.
Koch T, Lenz T, Rheude T, Cassese S, Xhepa E, Joner M, et al.
Catheter Cardiovasc Interv
. 2024 Sep;
104(5):909-917.
PMID: 39290129
Background: We previously showed non-inferiority of a low-dose paclitaxel-coated balloon (PCB) with citrate excipient (Agent PCB) as compared to normal-dose iopromide excipient (SeQuent Please PCB) in terms of angiographic and...
8.
Vrints C, Andreotti F, Koskinas K, Rossello X, Adamo M, Ainslie J, et al.
Eur Heart J
. 2024 Aug;
45(36):3415-3537.
PMID: 39210710
No abstract available.
9.
Teles R, Van Belle E, Parma R, Tarantini G, van Mieghem N, Mylotte D, et al.
EuroIntervention
. 2024 Aug;
PMID: 39207816
The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define...
10.
Lansky A, Baron S, Grines C, Tremmel J, Al-Lamee R, Angiolillo D, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(2):100016.
PMID: 39132570
No abstract available.